The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
765
May 6, 1988
View Complete Issue         Table of Contents 2019 
A More Potent Inactivated Polio Vaccine
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
A More Potent Inactivated Polio Vaccine
May 6, 1988 (Issue: 765)
The US Food and Drug Administration recently licensed a new Salk-type injectable polio vaccine (Poliovirus Vaccine Inactivated - Connaught) that is more potent in its antigenicity than any other inactivated polio vaccine (IPV) previously available...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: A More Potent Inactivated Polio Vaccine
Article code: 765b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.